A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer

Por Schelman, William R., Liu, Glenn, Wilding, George, Morris, Thomas, Phung, De, Dreicer, Robert
Publicado em 2009

Aggressive Adenocarcinoma of the Cervical Esophagus: Importance of a Multidisciplinary Approach

Por Fashoyin, Adedayo, Hartig, Gregory, Schelman, William R., Ritter, Mark, Agni, Rashmi, Gopal, Deepak V., Pfau, Patrick R., Weiss, Jennifer M.
Publicado em 2012

Quantitative Hepatic Perfusion Modeling using DCE-MRI with Sequential Breath-Holds

Por Bultman, Eric M., Brodsky, Ethan K., Horng, Debra K., Irarrazaval, Pablo, Schelman, William R., Block, Walter F., Reeder, Scott B.
Publicado em 2013

Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance

Por HADAC, JAMIE N., MILLER, DEVON D., GRIMES, IAN C., CLIPSON, LINDA, NEWTON, MICHAEL A., SCHELMAN, WILLIAM R., HALBERG, RICHARD B.
Publicado no Anticancer Res (2016)

High Spatial and High Temporal Resolution Dynamic Contrast-Enhanced Perfusion Imaging of the Liver with Time-Resolved 3D-Radial MRI

Por Brodsky, Ethan K., Bultman, Eric M., Johnson, Kevin M., Horng, Debra E., Schelman, William R., Block, Walter F., Reeder, Scott B.
Publicado em 2014

A Preclinical and Clinical Study of Lithium in Low-Grade Neuroendocrine Tumors

Por Lubner, Sam J., Kunnimalaiyaan, Muthusamy, Holen, Kyle D., Ning, Li, Ndiaye, Mary, LoConte, Noelle K., Mulkerin, Daniel L., Schelman, William R., Chen, Herbert
Publicado em 2011

A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma

Por Mohammed, Tabraiz A., Holen, Kyle D., Jaskula-Sztul, Renata, Mulkerin, Daniel, Lubner, Sam J., Schelman, William R., Eickhoff, Jens, Chen, Herbert, LoConte, Noelle K.
Publicado em 2011

The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumor...

Por Choi, Brian S., Alberti, Dona B., Schelman, William R., Kolesar, Jill M., Thomas, James P., Marnocha, Rebecca, Eickhoff, Jens C., Ivy, S. Percy, Wilding, George, Holen, Kyle D.
Publicado em 2010

A Phase I study of AT-101 with Cisplatin and Etoposide in patients with advanced solid tumors with an Expanded Cohort in Extensive-Stage Small Cell Lung Cancer

Por Schelman, William R., Mohammed, Tabraiz A., Traynor, Anne M., Kolesar, Jill M., Marnocha, Rebecca M., Eickhoff, Jens, Keppen, Michael, Alberti, Dona B., Wilding, George, Takebe, Naoko, Liu, Glenn
Publicado em 2013

Electron Paramagnetic Resonance Study of Peripheral Blood Mononuclear Cells from Patients with Refractory Solid Tumors Treated with Triapine(®)

Por Kolesar, Jill M., Schelman, William R., Geiger, Peter G., Holen, Kyle D., Traynor, Anne M., Alberti, Dona B., Thomas, James P., Chitambar, Christopher R., Wilding, George, Antholine, William E.
Publicado em 2007

Cytotoxic evaluation of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in peripheral blood lymphocytes of patients with refractory solid tumors using electron paramagnetic reso...

Por KOLESAR, JILL M., SACHIDANANDAM, KAMAKSHI, SCHELMAN, WILLIAM R., EICKHOFF, JENS, HOLEN, KYLE D., TRAYNOR, ANNE M., ALBERTI, DONA B., THOMAS, JAMES P., CHITAMBAR, CHRISTOPHER R., WILDING, GEORGE, ANTHOLINE, WILLIAM E.
Publicado em 2011

A Phase I Study of Triapine(®) in Combination with Doxorubicin in Patients with Advanced Solid Tumors

Por Schelman, William R., Morgan-Meadows, Sherry, Marnocha, Rebecca, Lee, Fred, Eickhoff, Jens, Huang, Wei, Pomplun, Marcia, Jiang, Zhisheng, Alberti, Dona, Kolesar, Jill M., Ivy, Percy, Wilding, George, Traynor, Anne M.
Publicado em 2008

Vorinostat in Combination with Bortezomib in Patients with Advanced Malignancies Directly Alters Transcription of Target Genes

Por Kolesar, Jill M., Traynor, Anne M., Holen, Kyle D., Hoang, Tien, Seo, Songwon, Kim, KyungMann, Alberti, Dona, Espinoza-Delgado, Igor, Wright, John J., Wilding, George, Bailey, Howard H., Schelman, William R.
Publicado em 2013

A phase I study of sorafenib, oxaliplatin and two days of high dose capecitabine in advanced pancreatic and biliary tract cancer: A Wisconsin Oncology Network Study

Por LoConte, Noelle K., Holen, Kyle D., Schelman, William R., Mulkerin, Daniel L., Deming, Dustin A., Hernan, Hilary R., Traynor, Anne M., Goggins, Timothy, Groteluschen, David, Oettel, Kurt, Robinson, Emily, Lubner, Sam J.
Publicado em 2012

A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma: A Wisconsin Oncology Network study

Por Frank, Daniel, Jumonville, Alcee, LoConte, Noelle K, Schelman, William R, Mulkerin, Daniel, Lubner, Sam, Richter, Katie, Winterle, Natalie, Wims, Mary Beth, Dietrich, Leah, Winkler, J. Mitchell, Volk, Michael, Kim, KyungMann, Holen, Kyle D.
Publicado em 2012

A Phase I Study of Intermittently Dosed Vorinostat in Combination with Bortezomib in Patients with Advanced Solid Tumors

Por Deming, Dustin A., Ninan, Jacob, Bailey, Howard H., Kolesar, Jill M., Eickhoff, Jens, Reid, Joel, Ames, Matthew M., McGovern, Renee M., Alberti, Dona, Marnocha, Rebecca, Espinoza-Delgado, Igor, Wright, John, Wilding, George, Schelman, William R.
Publicado em 2013

A Multicenter Phase 1 Study of γ -secretase inhibitor RO4929097 in Combination with Capecitabine in Refractory Solid Tumors

Por LoConte, Noelle K., Razak, Albiruni R. A., Ivy, Percy, Tevaarwerk, Amye, Leverence, Rachael, Kolesar, Jill, Siu, Lillian, Lubner, Sam J., Mulkerin, Daniel L., Schelman, William R., Deming, Dustin A., Holen, Kyle D., Carmichael, Lakeesha, Eickhoff, Jens, Liu, Glenn
Publicado no Invest New Drugs (2014)

Dynamic Tumor Growth Patterns in a Novel Murine Model of Colorectal Cancer

Por Olson, Terrah J. Paul, Hadac, Jamie N., Sievers, Chelsie K., Leystra, Alyssa A., Deming, Dustin A., Zahm, Christopher D., Albrecht, Dawn M., Nomura, Alice, Nettekoven, Laura A., Plesh, Lauren K., Clipson, Linda, Sullivan, Ruth, Newton, Michael A., Schelman, William R., Halberg, Richard B.
Publicado em 2013

Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies

Por Attia, Steven, Morgan-Meadows, Sherry, Holen, Kyle D., Bailey, Howard H., Eickhoff, Jens C., Schelman, William R., Traynor, Anne M., Mulkerin, Daniel L., Campbell, Toby C., McFarland, Thomas A., Huie, Michael S., Cleary, James F., Tevaarwerk, Amye J., Alberti, Dona B., Wilding, George, Liu, Glenn
Publicado em 2008

A Phase I Study of Vorinostat in Combination with Bortezomib in Patients with Advanced Malignancies

Por Schelman, William R., Traynor, Anne M., Holen, Kyle D., Kolesar, Jill M., Attia, Steven, Hoang, Tien, Eickhoff, Jens, Jiang, Zhisheng, Alberti, Dona, Marnocha, Rebecca, Reid, Joel M., Ames, Matthew M., McGovern, Renee M., Espinoza-Delgado, Igor, Wright, John J., Wilding, George, Bailey, Howard H.
Publicado em 2013